Medical Care Technologies (OTC Pink:MDCE) Outlines Regulatory Roadmap: Dividing AI Health Platform Into Clinical and Consumer Divisions

Core Insights - Medical Care Technologies Inc. is implementing a strategic plan to separate its AI health applications into two distinct divisions [1] - The first division will focus on clinical validation and regulatory approval, while the second will cater to consumer and research-based wellness monitoring [1] - The company's platform utilizes deep learning, computer vision, and biometric analytics to integrate various diagnostic and predictive modules [1] Company Strategy - The separation of AI health applications aims to enhance focus and efficiency in both clinical and consumer markets [1] - By creating distinct divisions, the company seeks to streamline processes for regulatory compliance and consumer engagement [1] Technology and Innovation - The proprietary platform of Medical Care Technologies Inc. is designed to leverage advanced technologies such as deep learning and computer vision [1] - The integration of multiple diagnostic and predictive modules positions the company as an innovator in AI-driven preventive healthcare [1]